EXCLUSIVE — Nearly 50 House Republicans are investigating efforts by the Biden-Harris administration to keep insurance premiums for Medicare prescription coverage low, which Republicans say is an illegitimate attempt to limit the fallout from the president’s drug-pricing policies in the 2024 campaign cycle.

Rep. Brett Guthrie (R-KY), the chairman of the Energy and Commerce Subcommittee on Health, told the Washington Examiner in an exclusive interview that Medicare Part D prescription drug premiums have dramatically increased since the passage of the Inflation Reduction Act in 2022, which was intended to lower healthcare costs for seniors.